FibroBiologics, Inc. Share Price
NASDAQ: FBLGFibroBiologics, Inc. Stock Performance
Open $0.99 | Prev. Close $0.99 | Circuit Range N/A |
Day Range $0.99 - $0.99 | Year Range $0.19 - $2.82 | Volume 590 |
Average Traded $0.99 |
FibroBiologics, Inc. Share Price Today
As of 11 August 2026, FibroBiologics, Inc.'s share price is $0.97. The stock opened at $0.99, compared to its previous close of $0.99. During today's trading session, FibroBiologics, Inc.'s share price traded between $0.99 and $0.99, with an average price of $0.99. Over the past 52 weeks, the stock has recorded a high of $2.82 and a low of $0.19. In terms of performance, FibroBiologics, Inc.'s share price has risen by 201.24% over the last six months and is up 65.25% on a year-on-year basis.
FibroBiologics, Inc. Share Price Chart
FibroBiologics, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $0.00 | Revenue (TTM) N/A | Return On Equity (TTM) N/A |
Profit Margin N/A | Debt to Equity N/A | Quarterly Earnings Growth YoY -1055.60% |
FibroBiologics, Inc. Quarterly Profit & Loss
All figures in USD
FibroBiologics, Inc. Annual Profit & Loss
All figures in USD
About FibroBiologics, Inc.
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
FibroBiologics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.80 | $0.99 | +41.43% |
Jul 2026 | $0.93 | $0.70 | -24.89% |
Jun 2026 | $1.12 | $0.93 | -17.52% |
May 2026 | $1.35 | $1.13 | -15.67% |
Apr 2026 | $1.10 | $1.34 | +2.29% |
Mar 2026 | $0.33 | $1.31 | +306.83% |
Feb 2026 | $0.32 | $0.32 | -3.01% |
Jan 2026 | $0.22 | $0.33 | +49.55% |
Dec 2025 | $0.28 | $0.22 | -18.38% |
Nov 2025 | $0.39 | $0.27 | -30.96% |
Oct 2025 | $0.55 | $0.39 | -24.81% |
Sep 2025 | $0.60 | $0.52 | -10.73% |